logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9925144 B1

PDFFull Text
Date of Patent:
Mar. 27, 2018

Filed:

Jul. 18, 2014

Heat-stable dry powder pharmaceutical compositions and methods

Applicant:

Mannkind Corporation, Valencia, CA (US);

Inventors:

Karine Fabio, Woodbury, CT (US);

Joseph J. Guarneri, Stamford, CT (US);

Kieran Curley, Cos Cob, CT (US);

Marshall L. Grant, Newtown, CT (US);

Andrea Leone-Bay, Ridgefield, CT (US);

Assignee:

MannKind Corporation, Westlake Village, CA (US);

Attorneys:

K&L Gates LLP

Louis C. Cullman

Hal Gibson

Primary Examiner:

Satyanarayana R Gudibande

Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 38/11 (2006.01); A61K 38/23 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01); A61K 38/29 (2006.01); A61K 45/06 (2006.01); A61K 31/198 (2006.01); A61K 31/4172 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1623 (2013.01); A61K 9/0073 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 31/198 (2013.01); A61K 31/4172 (2013.01); A61K 38/11 (2013.01); A61K 38/12 (2013.01); A61K 38/23 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 38/29 (2013.01); A61K 45/06 (2013.01);
Abstract

Disclosed herein are heat-stable dry powders which include peptides or protein such as oxytocin for use as a pharmaceutical composition. The composition is highly stable at increased temperatures and relatively high humid environments, and are intended for storage at room temperature with an improved shelf-life. In particular, the dry powders are intended for inhalation, however, other routes of administration can be used when reconstituted in solution.

Find Patent Forward Citations

Fabio, Karine. (2018). Heat-stable dry powder pharmaceutical compositions and methods (U.S. Patent No. 9925144). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9925144

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…